EDIT-B®
Blood test to differentiate unipolar depression from bipolar disorder
EDITOX®
Cell-based solutions to mimic drug impact on RNA editing
EDITECH®
Integrated platform from RNA / DNA sequencing to machine learning and AI
Meet us
Society of Biological Psychiatry (SOBP)
Annual Meeting 2025 – From April 24 to 26, 2025 in Toronto
The SOBP Annual Meeting, focusing on “Artificial Intelligence and Mental Health: A New Landscape for Research and Practice”, provides a fantastic platform for learning and discovery in the field of biological psychiatry.
We are thrilled to share that our CSO, Dr. Dinah Weissmann, will be presenting a poster entitled “RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar and Schizoaffective Disorders”, on Friday, April 25th at 5 PM EDT.
If you are attending the 2025 SOBP Annual Meeting, we warmly invite you to join Dr. Weissmann’s poster session to learn more about this exciting new frontier in diagnosing psychiatric illnesses!
Innovative Diagnostic Company
ALCEDIAG is an innovative diagnostic company specializing in the development and commercialization of blood tests, monitoring solutions, and companion diagnostics, primarily for mental health. These offerings are based upon the company’s distinctive expertise in epigenetics, RNA, and Artificial Intelligence, complemented by neurosciences and psychiatry.
ALCEDIAG’s unique approach is protected by seven patent families and supported by a global network of Key Opinion Leaders, who serve both as advocate for and early adopt of ALCEDIAG’s solutions.